Skip to content
FFF212121

Drawing based on the description in the official product monograph. No photo yet.

“70 mg: White to off-white, oval, biconvex, uncoated tablets debossed with 'F' on one side and '21' on the other side”

F 21 pill

Pill with imprint F 21 is white, oval and has been identified as Alendronate 70 mg. It is used for osteoporosis (weak bones). It is supplied by Auro Pharma Inc.

Sold in Canada

Alendronate 70 mg

Brand
Auro-Alendronate
Imprint
F 21
Strength
70 mg
Used for
Osteoporosis (weak bones)
Color
White
Shape
Oval
Form
Tablet
Manufacturer
Auro Pharma Inc
Drug class
Bone medicine (bisphosphonate)
Sold in
Canada
DIN
02388553

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Alendronate pills and guides

What is Alendronate used for?

Alendronate is used for osteoporosis (weak bones).

Medicine type
Bone medicine (bisphosphonate)
Official uses from the US prescribing label

Treatment of Osteoporosis in Postmenopausal Women

Alendronate sodium tablets, USP are indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, alendronate sodium tablets, USP increases bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures).

Prevention of Osteoporosis in Postmenopausal Women

Alendronate sodium tablets, USP are indicated for the prevention of postmenopausal osteoporosis.

Treatment to Increase Bone Mass in Men with Osteoporosis

Alendronate sodium tablets, USP are indicated for treatment to increase bone mass in men with osteoporosis.

Treatment of Glucocorticoid-Induced Osteoporosis

Alendronate sodium tablets, USP are indicated for the treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density.

Treatment of Paget's Disease of Bone

Alendronate sodium tablets, USP are indicated for the treatment of Paget's disease of bone in men and women. Treatment is indicated in patients with Paget's disease of bone who have alkaline phosphatase at least two times the upper limit of normal, or those who are symptomatic, or those at risk for future complications from their disease.

Important Limitations of Use

The optimal duration of use has not been determined. The safety and effectiveness of alendronate sodium for the treatment of osteoporosis are based on clinical data of four years duration. All patients on bisphosphonate therapy should have the need for continued therapy re-evaluated on a periodic basis. Patients at low-risk for fracture should be considered for drug discontinuation after 3 to 5 years of use. Patients who discontinue therapy should have their risk for fracture re-evaluated periodically.

From the FDA-approved label on DailyMed (published Jul 06, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows F 21. The parts can be split between the two sides, so turn the pill over and check both.
  • It is white, oval.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Auro-Alendronate by Auro Pharma Inc.

In Canada: prescription only.

Ingredients

Active: Alendronic Acid (Alendronate Sodium)

Other pills with imprint F 21

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Alendronate pills